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DURATION 
 
Reading Time: 10 minutes 
Writing Time: 180 minutes 
 
INSTRUCTIONS TO CANDIDATES 
 
This examination has 2 (A and B) Sections: 
Section A contains Forty (40) Multiple Choice Questions.  Answer all questions on the Faculty/School supplied 
Multiple Choice Answer Sheet.  Total marks allocated: Twenty (20). 
Suggested time allocation: One (1) hour. 
Section B contains Ten (10) Extended-Answer Questions.  Answer any Eight (8) questions only in the 20-page 
Booklet provided.  Total marks allocated: Eighty (80). 
Suggested time allocation: Two (2) hours. 
 
EXAM CONDITIONS 
You may begin writing from the commencement of the examination session.  The reading time indicated above is 
provided as a guide only. 
This is a CLOSED BOOK examination 
No calculators are permitted 
No handwritten notes are permitted 
No dictionaries are permitted 
 
ADDITIONAL AUTHORISED MATERIALS EXAMINATION MATERIALS TO BE SUPPLIED 
 




1 x 20 Page Book 
1 x Scrap Paper 
College Multiple Choice Answer Sheet 
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Section A 
Multiple Choice Questions 
Total No. of Marks for this Section: 20 
Please write the answers for this section on the 100-MCQ Answer Sheet provided. Ensure that your 
name and student number have been written on the answer sheet. 
Answer ALL (40) questions 
0.5 mark for each question.  Suggested Time allocation for Section A:  60 mins 
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Total No. of Marks for this Section: 80 
Please answer this section in the 20-page Answer Booklet provided.  Ensure that your name and student 
number have been written on the front page of the answer booklet. 
Answer any EIGHT (8) questions. 
Marks for each question are indicated.  Suggested time allocation: 120 mins 
 
Question 1 
Mr HC has a history of coronary heart disease and his medications include: 
 
 
a. Describe the therapeutic use(s) and mechanisms of action of the active ingredients in 
Vytorin. 
  (8 marks) 
b. What are the consequences if Mr HC is not compliant with taking this medication? 





Question 2 (multiple topics) 
a. Explain why the activity for a local anaesthetic could be reduced when it is injected into areas 
with inflammation.  
 (5 marks) 
b. Describe the mechanism by which digoxin affects myocardial contractility and benefit a patient 
with heart failure. 
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a. Describe the mechanisms of action of the active ingredients in Asasantin. 
  (7 marks) 
b. What are the consequences if a patient is not compliant with taking this medication? 




Question 4 (multiple topics) 
a. Triple therapy (omeprazole, amoxicillin and clarithromycin) is often required for the treatment 
of peptic ulcers.  Describe the mechanism of action of omeprazole and explain when this 
therapy is necessary. 
 (5 marks) 
b. Describe the mechanisms of action of nitrates in relieving the signs and symptoms of angina. 





a. Describe and differentiate the mechanism(s) of action and clinical uses of amlodipine and 
verapamil. 
  (6 marks) 
b. List FOUR (4) adverse effects or risks associated with the use of these agents. 
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Describe the adverse effects which could be expected when a non-selective  (beta)-adrenoceptor 
antagonist is used in patients with the following co-morbidities: 
a. Raynaud’s Disease (2 marks) 
b. Congestive heart failure (2 marks) 
c. Asthma (2 marks) 
d. Diabetes mellitus (4 marks) 









When warfarin therapy is initiated in a patient suffering from deep vein thrombosis (DVT) or atrial 
fibrillation (AF), it is necessary to co-administer heparin for the first 5-7 days. 
a. Describe the mechanism of action of heparin and warfarin. 
 (5 marks) 
b. Explain why there is a requirement for heparin co-administration when commencing 
warfarin therapy. 
 (3 marks) 
c. What are the antidotes for heparin and warfarin overdose?  Explain how they work. 
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Ms RS is currently taking amiodarone. 
a. What disorder is Ms RS likely to be suffering from? (1 mark) 
b. Describe the mechanism(s) of action of amiodarone and explain how it benefits Ms RS. 
 (6 marks) 
c. A loading dose of amiodarone is needed when commencing the treatment.  Explain what 
is meant by “loading dose” and the reason for this requirement. 
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a. Describe the mechanisms of action of furosemide (frusemide) and spironolactone in diuresis.  
Which one is more powerful/effective?  Explain your answer. 
  (6 marks) 
b. Therapy with furosemide and spironolactone can change the concentrations of potassium in 
blood.  Explain how these changes affect the activity of digoxin. 












End of Sections B 
 
End of Exam Paper 
 
 
